Results 241 to 250 of about 16,996 (279)

Prevalence of non‐alcoholic fatty liver disease and its association with different combinations of weight status and metabolic abnormalities in children aged 6–18 years

open access: yesPediatric Investigation, EarlyView.
Children with non‐overweight combined with metabolic risk factors might increase the risk of non‐alcoholic fatty liver disease (NAFLD). These findings suggest that overweight and obesity should not be the sole criterion for NAFLD screening in children. In particular, more attention should be given to non‐overweight combined with metabolic abnormalities
Peiyu Ye   +22 more
wiley   +1 more source

Monogenic and syndromic obesity in children: Clinical recognition, genetics, and precision management

open access: yesPediatric Investigation, EarlyView.
Monogenic and syndromic obesity in children often arises from defects in the leptin–melanocortin pathway. Understanding these rare genetic causes not only clarifies mechanisms of appetite regulation but also enables precision therapies, offering hope beyond lifestyle interventions.
Hadel Khalil   +2 more
wiley   +1 more source

Novel RNA-Based Therapies in the Management of Dyslipidemias. [PDF]

open access: yesInt J Mol Sci
Kosmas CE   +5 more
europepmc   +1 more source

Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This study validates commonly used non‐invasive tests for liver fibrosis in morbidly obese patients with biopsy‐proven MASLD and evaluates outcomes after bariatric surgery. These non‐invasive tests show low diagnostic accuracy for baseline liver fibrosis, while bariatric surgery significantly improves liver stiffness, metabolic profiles, and ...
Parinda Prathyajuta   +8 more
wiley   +1 more source

The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study. [PDF]

open access: yesJ Endocrinol Invest
Formisano E   +6 more
europepmc   +1 more source

Fast Quantitative Evaluation of the Amelioration Effect in MASLD During Semaglutide Treatment Using Ultrasound‐Derived Fat Fraction and Fat‐to‐Muscle Ratio

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a chronic liver disease. Research into a feasible, rapid, and effective assessment method is crucial for evaluating the therapeutic effects of semaglutide in MASLD. This prospective study utilized ultrasound‐derived fat fraction measurement and fat‐to‐muscle ratio to evaluate hepatic ...
Yunlin Huang   +10 more
wiley   +1 more source

Dyslipidemia

Annals of Internal Medicine, 2023
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking.
Marios Arvanitis, Charles J. Lowenstein
openaire   +2 more sources

Home - About - Disclaimer - Privacy